BAUSCH HEALTH COS INC (BHC) Stock News

Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program

Bausch Health Provides Update on Strategic Alternatives

Tesla, Nvidia, GM And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Bausch Health to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025

Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program

Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb

Deal Dispatch: Ubisoft In Buyout Talks, Dental Supplier Explores Sale, Beloved Drive-Through Goes Bankrupt

Dental supply maker Patterson Companies Inc announced Thursday that it is exploring strategic options, including a sale or merger, to boost shareholder value.

Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness Day

Bausch Health Appoints New Chief Medical Officer and Head of R&D

Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis

PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS

Bausch Health Announces Third Quarter 2024 Results

ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence

Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024

Bausch Health and Salix Survey Highlights Urgent Need for Improved Understanding of Liver Disease Across Healthcare Provider Disciplines as Prevalence of Cirrhosis Rises

Bausch Health: A Buyout Bid Could Be the Ticket to Unlock Value

The potential sale of Bausch + Lomb, Bausch Health's eye care business, could result in a financial gain for the company by reducing its debt burden.

Bausch Health Taps Jefferies to Refinance Debt, Aid Spinoff

Bausch Health Cos. is working with Jefferies Financial Group to explore refinancing some of its debt to aid a long-planned spinoff of its stake in the eye-care company Bausch + Lomb, according to people with knowledge of the situation.

Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It?

Bausch + Lomb is reportedly considering a sale. But its potential acquirers could come up against antitrust concerns.

Bausch + Lomb Soars on Report That It’s Exploring a Sale

Bausch + Lomb Corp. shares rose the most ever following a report that the eye-care company is considering selling itself to disentangle from its debt-laden parent company.

Bausch Health Announces 2024 Gastrointestinal Health Scholars Program Winners

Bausch Health Announces Second Quarter 2024 Results

BHC Stock Plunges as Bausch Health Appears on the Brink of Bankruptcy

Although Bausch Health has denied rumors that it’s on the cusp of bankruptcy, BHC stock is nevertheless suffering from skepticism.